HELLP syndrome, A Real General Disease that Threatens the Maternal Morbidity and Mortality at the EHU in Oran
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Zelmat S, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Medhioub KF, ChaariA, Turki O, Rgaieg K , Baccouch N , et al. (2016) Actualités sur le syndrome Hellp (Hemolysis, ElevatedLiver enzymes and LowPlatelets); revmed interne 37: 406-411. Link: https://bit.ly/3aIn7re
Weinstein L (1982) Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. ;Am J Obstet Gynecol 142: 159-167. Link: https://bit.ly/2VKeM1U
Pourrat O, Pierre F, Magnin G (2009) Le syndrome HELLP: les dix commandements. Revue de médecine interne 30: 58-64. Link: https://bit.ly/2W6AU5C
Bacq Y (1997) Acute fatty liver in pregnancy. Gastroenterol Clin Biol 21: 109-115. Link: https://bit.ly/2yUWNga
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, et al. (1993) Maternalmorbidity and mortalityin 442 pregnancieswithhemolysiselevatedliver enzymes and lowplatelets (HELLP syndrome). Am J Obstet Gynecol 169: 1000-1006. Link: https://bit.ly/2KITQlB
Beaufils M (2002) Hypertension artérielle gravidique. Rev Med Interne 23: 927-938.
Carles G (2009) Hellp syndrome/Formes cliniques et étiologies alternatives. Obstétrique 2009. URL: https://bit.ly/3cVVk8c
Martin JN, Rose CH, Briery CM (2006) Understanding and managing HELLP syndrome: the integralrole of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195: 914-934. Link: https://bit.ly/3aH32la
Martin JN, Blake PG, Perry KG, Mc Ccaul JF, Hess LW, et al. (1991)The naturalhistory of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 164: 1500-1509. Link: https://bit.ly/35e8jzs
Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46: 1243-1249. Link: https://bit.ly/2y1nFvf
Barton JR, Sibai BM (1991) Care of the pregnancycomplicated by HELLP syndrome. Obstet Gynecol Clin North Am 18: 165-179, Link: https://bit.ly/2xhSDP6
Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM (2000) Riskfactors for adverse maternaloutcomesamongwomenwith HELLP (hemolysis, elevatedliver enzymes, and lowplatelet count) syndrome. Am J Obstet Gynecol 183: 444-448. Link: https://bit.ly/2VKdzb0
Beucher G,Simonet T, Dreyfus M (2008) Prise en charge du HELLP syndrome. Gynecol Obstet Fertil 36: 1175-1190. Link: https://bit.ly/2YgmqTj
Edouard D (2000) Le syndrome Hellp,Vers une définition de la durée du traitement conservateur. Ann Fr Anesth Réanim 19 : 710-127. Link: https://bit.ly/3f1yDRV
LeBoterff C, Masson D (2003) Decouverte d'un Hellp syndrome asymptomatique chez une jeune femme drepanocytaireheterozygote A/S. Revue Française des laboratoires 57-59. Link: https://bit.ly/2SkP7uy
Kirkpatrick CA (2010) The help syndrome; Acta Clinica Belgica 65: 91-97. Link: https://bit.ly/3bOIusm
Roopa S, Hegde HV, BhatPai R, Yaliwal VG, RaghavendraRao P (2010) A case of atypical HELLP (hemolysis, elevatedliver enzymes and lowplatelet count) syndrome presenting as bleedingfrom the epiduralpuncture site during; labour. Current Anaesthesia Critical Care 21: 153-155. Link: https://bit.ly/3aIkLbS
Mamouni N, Bougern H, Derkaoui A, Bendahou K, Fakir S, et al. (2012) Le HELLP syndrome: à propos de 61 cas et revue de la littérature. Pan Afr Med J 11: 30. Link: https://bit.ly/3d14sZ4
Sibai BM, Ramadan MK (1993) Acuterenalfailure in pregnanciescomplicated by hemolysis, elevatedliver enzymes and lowplatelets. Am J Obstet Gynecol 168:1682-1690. Link: https://bit.ly/2KGgxHh
Robert S, Egerman MD, Baha M, Sibai MD (1999) Hellp syndrome; Clin Obst et Gynecol 42: 381-389. Link: https://bit.ly/2YeQK0D
BenLetaifa D, Ben Hamada S, Salem N, Ben Jazia K, Slama A, et al. (2000) Morbidité et mortalité materno-foetales associées auHellp syndrome: Ann Fr AnesthRéanim 19 : 712-718. Link: https://bit.ly/3f3HWAU